Development and validation of stability-indicating RP-HPLC method for estimation of dalfampridine in bulk drug and tablet dosage form

• Päätekijät: Dipali Bagal (Tekijä), Akhil Nagar (Tekijä), Aditya Joshi (Tekijä), Aishwarya Chachare (Tekijä), Atul Shirkhedkar (Tekijä), Saurabh Khadse (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SpringerOpen, 2021-04-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background In the current study, a simple, improved, precise, rapid, and accurate reverse phase liquid chromatographic method was produced for the estimation of dalfampridine in bulk and tablet dosage form which is a potassium channel blocker used for the treatment of multiple sclerosis (MS...